Abstract
Question: To assess the incidence, characteristics, aetiology, risk factors and mortality of acute respiratory distress syndrome (ARDS) in ICU patients with community-acquired pneumonia (CAP) using the Berlin definition.
Methods: We prospectively enrolled consecutive mechanically-ventilated ICU adults with CAP over 20 years, compared with mechanically-ventilated patients without ARDS. The main outcome was 30-day mortality.
Results: Among 5,334 patients hospitalized with CAP, 930 (17%) were admitted to the ICU, and 432 required mechanical ventilation; 125 (29%) cases met the Berlin ARDS criteria. ARDS was present in 2% of hospitalized patients and 13% of ICU patients. Based on the baseline PaO2/FiO2, 60 (48%), 49 (40%), and 15 (12%) patients had mild, moderate, and severe ARDS, respectively. Streptococcus pneumoniae was the most frequent pathogen, with no significant differences in aetiology between groups. Higher organ system dysfunction and previous antibiotic use were independent risk factors for ARDS in the multivariate analysis, while previous inhaled corticosteroids was independently associated with a lower risk. The 30-day mortality was similar between patients with and without ARDS (25% vs. 30%, p=0.25), confirmed by propensity-adjusted multivariate analysis.
Conclusions: ARDS occurs as a complication of CAP in 29% of mechanically-ventilated patients, but is not related to the aetiology or mortality.
Abstract
In patients with community-acquired pneumonia, the incidence of acute respiratory distress syndrome based on the Berlin definition was 2% among all patients in hospital, 13% among patients in intensive care, and 29% among patients receiving mechanical ventilation. Acute respiratory distress syndrome was not related to the aetiology or mortality in this population
In mechanically-ventilated patients with community-acquired pneumonia, ARDS based on the Berlin criteria was not related to the aetiology or mortality.
Footnotes
This manuscript has recently been accepted for publication in the European Respiratory Journal. It is published here in its accepted form prior to copyediting and typesetting by our production team. After these production processes are complete and the authors have approved the resulting proofs, the article will move to the latest issue of the ERJ online. Please open or download the PDF to view this article.
Conflict of interest: Dr. Cilloniz has nothing to disclose.
Conflict of interest: Dr. Ferrer has nothing to disclose.
Conflict of interest: Dr. Liapikou has nothing to disclose.
Conflict of interest: Dr. Garcia-Vidal has nothing to disclose.
Conflict of interest: Dr. Gabarrus has nothing to disclose.
Conflict of interest: Dr. Ceccato has nothing to disclose.
Conflict of interest: Dr. Blasi has nothing to disclose.
Conflict of interest: Dr. Torres has nothing to disclose.
Conflict of interest: Dr. Puig de la Bellacasa has nothing to disclose.
- Copyright ©ERS 2018